US2022178810A1PendingUtilityA1
Hydrogel particles with tunable optical properties
Est. expiryApr 6, 2032(~5.7 yrs left)· nominal 20-yr term from priority
G01N 2015/1415G01N 2021/6439G01N 15/14G01N 15/1012G01N 2015/1006G01N 21/6428G01N 2015/149G01N 2015/1018G01N 2015/1014G01N 15/149
77
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present disclosure relates to compositions comprising a hydrogel particle with optical properties substantially similar to the optical properties of a target cell, and methods for their use.
Claims
exact text as granted — not AI-modified1 . (canceled)
2 . A population of hydrogel particles, each hydrogel particle comprising:
(i) a polymer comprising a polymerized monomer and a bifunctional monomer; (ii) DNA encapsulated within the hydrogel particle; and (iii) a nanoparticle encapsulated within the hydrogel, wherein the population hydrogel particles has an optical property that is substantially similar to a corresponding property of a target cell, the optical property provided by the polymerized monomer, bifunctional monomer, or the encapsulated nanoparticle.
3 . The population of hydrogel particles of claim 2 wherein the polymerized monomer is lactic acid, glycolic acid, acrylic acid, 1-hydroxyethyl methacrylate, ethyl methacrylate, propylene glycol methacrylate, acrylamide, N-vinylpyrrolidone, methyl methacrylate, glycidyl methacrylate, glycol methacrylate, ethylene glycol, fumaric acid, methacrylamide, N-alkylacrylamide, N-alkylmethacrylamide, N,N-dialkylacrylamide, N-[(dialkylamino)alkyl]acrylamide, N-[(dialkylamino)alkyl]methacrylamide, (dialkylamino)alkyl acrylate, or (dialkylamino)alkyl methacrylate.
4 . The population of hydrogel particles of claim 2 , wherein the polymerized monomer is polymerized acrylamide.
5 . The population of hydrogel particles of claim 2 , where the bifunctional monomer comprises one or more chemical side groups that are capable of reacting with a dye molecule.
6 . The population of hydrogel particles of claim 5 , wherein the one or more chemical side groups is amine, carboxyl, maleimide, epoxide or alkyne.
7 . The population of hydrogel particles of claim 2 , wherein the bifunctional monomer is allyl amine, allyl acrylate, allyl methacrylate, allyl alcohol, allyl isothiocyanate, allyl chloride, allyl maleimide, or bis-acrylamide.
8 . The population of hydrogel particles of claim 7 , wherein the bifunctional monomer is bis-acrylamide.
9 . The population of hydrogel particles of claim 8 , wherein the bisacrylamide is N,N′-methylenebisacrylamide, N,N′-methylenebismethacrylamide, N,N′-ethylenebisacrylamide, N,N′-ethylenebis-methacrylamide, N,N′propylenebisacryl amide, or N,N′-(1,2-dihydroxyethylene)bisacrylamide.
10 . The population of hydrogel particles of claim 2 , wherein the polymerized monomer is acrylamide and the bifunctional monomer is bis-acrylamide.
11 . The population of hydrogel particles of claim 2 , wherein the encapsulated nanoparticle is polymethyl methacrylate (PMMA), polystyrene (PS), or silica.
12 . The population of hydrogel particles of claim 11 , wherein the encapsulated material is PMMA.
13 . The population of hydrogel particles of claim 11 , wherein the encapsulated material is PS.
14 . The population of hydrogel particles of claim 11 , wherein the encapsulated material is silica.
15 . The population of hydrogel particles of claim 10 , wherein the encapsulated nanoparticle is polymethyl methacrylate (PMMA), polystyrene (PS), or silica.
16 . The population of hydrogel particles of claim 15 , wherein the encapsulated material is PMMA.
17 . The population of hydrogel particles of claim 15 , wherein the encapsulated material is PS.
18 . The population of hydrogel particles of claim 15 , wherein the encapsulated material is silica.
19 . The population of hydrogel particles of claim 2 , comprising up to 1500 μg/mL of DNA.
20 . The population of hydrogel particles of claim 2 , comprising 40 ug/mL to 1000 ug/mL of DNA.
21 . The population of hydrogel particles of claim 2 , further comprising a dye.
22 . The population of hydrogel particles of claim 21 , wherein the dye is conjugated to the bifunctional monomer.
23 . The population of hydrogel particles of claim 2 , having a refractive index between 1.1 and 2.9.
24 . The population of hydrogel particles of claim 23 , wherein the hydrogel particles have an average refractive index of greater than about 1.7.
25 . The population of hydrogel particles of claim 2 , wherein the hydrogel particles have an average diameter in the range of from 5 μm to 100 μm.
26 . The population of hydrogel particles of claim 25 , wherein no more than 10% of the hydrogel particles have a diameter exceeding the average diameter of the hydrogel particles by more than 10%.
27 . The population of hydrogel particles of claim 2 , wherein the optical property comprises side scattering.
28 . The population of hydrogel particles of claim 27 , wherein the side scattering is within 10% of a target cell.
29 . The population of hydrogel particles of claim 2 , wherein the optical property comprises forward scattering.
30 . The population of hydrogel particles of claim 29 , wherein the forward scattering is within 10% of a target cell.
31 . The population of hydrogel particles of claim 2 , wherein the optical properties are measured using flow cytometry.
32 . A population of hydrogel particles, each hydrogel particle comprising:
(i) a polymer comprising polymerized acrylamide and bis-acrylamide; and (ii) DNA encapsulated within the hydrogel particle; wherein the population hydrogel particles has an average diameter in the range of from 5 μm to 100 μm, and no more than 10% of the hydrogel particles have a diameter exceeding the average diameter of the hydrogel particles by more than 10%.
33 . The population of hydrogel particles of claim 32 , having a refractive index between 1.1 and 2.9.
34 . The population of hydrogel particles of claim 33 , wherein the hydrogel particles have an average refractive index of greater than about 1.7.+
35 . The population of hydrogel particles of claim 32 , wherein having a side scattering within 10% of a target cell.
36 . The population of hydrogel particles of claim 32 , having a forward scattering within 10% of a target cell.Join the waitlist — get patent alerts
Track US2022178810A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.